WebDec 10, 2024 · For more information on MYR, please visit the company's website at www.myr-pharma.com. About Gilead Sciences . Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers ... WebDec 10, 2024 · FOSTER CITY, Calif.& BAD HOMBURG, Germany---- Gilead Sciences, Inc. and MYR GmbH, a German biotechnology company focused on the development and commercialization of therapeutics for the...
Gilead Sciences to acquire German biotech firm MYR for $1.4bn
WebGilead Sciences is all about cancer these days, right? COVID-19 saw its infectious disease credentials reinstated this year, and, now, it’s doubling down with a deal to buy out MYR. WebApr 11, 2024 · 17 Wall Street analysts have issued 1-year target prices for Gilead Sciences' stock. Their GILD share price forecasts range from $70.00 to $112.00. On average, they anticipate the company's stock price to reach $89.40 in the next year. This suggests a possible upside of 7.2% from the stock's current price. View analysts price targets for … mid thigh inexpensive winter coats
HEPATO UPDATE 2024 Frankfurt - medupdate
WebAfter helping lead MYR Pharmaceuticals to a €1.15 billion exit to Gilead Sciences last December, Thomas Christély is ready for his next challenge as the new CEO of MetrioPharm. WebFor more information on MYR, please visit the company's website at?www.myr-pharma.com. About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and … WebDec 10, 2024 · By Alex Keown. BioSpace. Gilead Sciences bolstered its capabilities in treating Hepatitis and other liver diseases with the €1.15 billion ($1.4 billion) cash acquisition of Germany-based Myr GmbH, a … mid thigh gym shorts